NanoViricides: Drug Candidates Show Fantastic Results In Animal Model
    Featured
    May 20, 2020

    NanoViricides: Drug Candidates Show Fantastic Results In Animal Model

    In our earlier pieces, we have provided an in-depth coverage of the promising biopharma smallcap…
    NanoViricides Develops Highly Effective Broad-Spectrum Drug Candidates Against Coronaviruses
    Featured
    May 12, 2020

    NanoViricides Develops Highly Effective Broad-Spectrum Drug Candidates Against Coronaviruses

    NanoViricides Develops Highly Effective Broad-Spectrum Drug Candidates Against Coronaviruses Shelton, Connecticut — May 12, 2020…
      NanoViricides: Drug Candidates Show Fantastic Results In Animal Model
      Featured
      May 20, 2020

      NanoViricides: Drug Candidates Show Fantastic Results In Animal Model

      In our earlier pieces, we have provided an in-depth coverage of the promising biopharma smallcap NanoViricides Inc. (NYSE American: NNVC)…
      NanoViricides Develops Highly Effective Broad-Spectrum Drug Candidates Against Coronaviruses
      Featured
      May 12, 2020

      NanoViricides Develops Highly Effective Broad-Spectrum Drug Candidates Against Coronaviruses

      NanoViricides Develops Highly Effective Broad-Spectrum Drug Candidates Against Coronaviruses Shelton, Connecticut — May 12, 2020 — NanoViricides, Inc. (NYSE American: NNVC)…
      Pressure BioSciences Acquisitions, Re-branding, And New CEO Could Lead To Profits
      Featured
      May 11, 2020

      Pressure BioSciences Acquisitions, Re-branding, And New CEO Could Lead To Profits

      In our recent coverage on Pressure BioSciences, Inc. (OTCQB: PBIO), the world’s leading player in high-pressure-based instruments, consumables and technology,…
      Back to top button
      Close